April 25th 2024
At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
1st Annual IKA Keratoconus Symposium: Front to Back and Everything In Between
View More
17th Annual Controversies in Modern Eye Care
View More
(COPE Credit) Community Practice Connection™: Pearls in Co-managing Glaucoma – Multidisciplinary Management in a Multitude of Treatment Options
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connection™: Pearls in Co-managing Glaucoma – Multidisciplinary Management in a Multitude of Treatment Options
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
Cases & Conversations™: Addressing Challenges In The Diagnosis And Management Of Neurotrophic Keratitis
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)
View More
Vance Thompson Vision - Fargo
September 20, 2024
Register Now!
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)
View More
EyeCon 2024
September 27-28, 2024
Register Now!
Vance Thompson Vision - Montana
October 18, 2024
Register Now!
Vance Thompson Vision - Omaha
October 25, 2024
Register Now!
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
The challenges of identifying glaucoma progression
September 18th 2015From advances in medical technology and testing to increased awareness among the public, eyecare professionals are better able to identify glaucoma before it starts wreaking havoc on a patient's vision. But when it comes to identifying glaucoma progression, things get a little murkier.
Not knowing IOPs can make you a better clinician
August 11th 2015With that in mind, there are several aspects of my own EHR software that I really appreciate over paper charts. Besides the fact that I can actually read what I wrote (or typed), one thing that I particularly enjoy is the fact that I am able to consistently look at a new patient’s optic nerves without knowing his or her intraocular pressure (IOP) values beforehand.
Is glaucoma a neurological disease?
June 16th 2015For years now, there has been considerable evidence indicating that glaucoma should be considered a neurological disease and not an entity isolated to the eyes alone. Perhaps the most compelling evidence for such a characterization is the fact that the retinal ganglion cells affected by glaucoma do not synapse until they arrive at the midbrain (specifically, the lateral geniculate nucleus).
Fast forward 10 years: How will we treat myopia?
May 31st 2015Liverpool, UK-The British Contact Lens Association meeting features several panel discussion on a theme. Topics included a look into the future for managing myopia and contact lens discomfort. In addition, improve the success of your multifocal contact lens fits with expert suggestions.
Field defect, high IOP might not signal glaucoma
February 6th 2015Glaucoma is a term that describes a family of progressive optic neuropathies. All of the glaucomas share characteristic and progressive cupping of the optic nerve head, and this cupping is most easily viewed by means of direct stereoscopic evaluation through a dilated pupil.
A clinical perspective of neovascular glaucoma
December 11th 2014Neovascular glaucoma is a potentially devastating ocular consequence of pathologic neovascularization of intraocular tissue. The symptoms include vision loss caused by both the underlying etiology (such as retinal vascular disease) as well as increased intraocular pressure (IOP), often accompanied by corneal edema, hyphema, or vitreous hemorrhage.
Using glaucoma diagnostic imaging
November 24th 2014Over the last decade, there has been rapid growth in the management of glaucoma. Innovative imaging technologies that aid in the diagnosis of this vision-threatening disease have also been on the rise. Instead of relying on a single diagnostic tool, clinicians may consider leveraging the benefits of several modalities available today.
Rapper’s wife receives controversial implant to change eye color
October 31st 2014Your patients may have seen wife of rapper T.I. and reality star Tameka “Tiny” Harris appear on Good Morning America this week to reveal she had undergone surgery to permanently change her brown eyes to “ice gray,” sparking a national conversation about the safety of such a procedure.
Most fluoroquinolones use not connected with glaucoma risk
October 31st 2014A recent study published in the Journal of Glaucoma found that there was no detected increase in glaucoma risk with current, recent, or past use of systemic fluoroquinolones, but did find a minimal statistically significant increased risk with distant use.